Exploring the Inducing Mechanism of Nerve Trauma on ALS Occurrence
What is amyotrophic lateral sclerosis?
Amyotrophic lateral sclerosis (ALS), also referred to as Lou Gehrig’s disease, is a progressive neurodegenerative disorder that impacts nerve cells within the brain and spinal cord. Motor neurons extend from the brain down to the spinal cord, and from the spinal cord out to muscles across the entire body. In ALS, the gradual deterioration of motor neurons ultimately results in their death. When a motor neuron perishes, the brain loses its capacity to initiate and regulate muscle movement.
ALS typically manifests initially with muscle twitches, limb weakness, or slurred speech. Eventually, the condition impairs control over the muscles essential for movement, speech, swallowing, and breathing. Currently, there is no cure for ALS, and the disease is ultimately fatal.
In 1993, researchers identified that mutations in the SOD1 gene lead to the production of abnormal copper/zinc superoxide dismutase (SOD1), a factor linked to roughly 20% of familial ALS cases. The SOD1 enzyme acts as a potent antioxidant, shielding the body from free radical damage originating in mitochondria. Free radicals are highly reactive molecules generated by cells during routine metabolic processes. These molecules can accumulate and damage cellular DNA and proteins. When the body’s oxidative stress defense system fails, cells undergo apoptosis, which in turn causes progressive muscle paralysis.
Individuals engaged in high-intensity physical activity, such as professional athletes and military personnel, have a higher risk of developing ALS. In certain instances, the disease seems to onset following an injury, with muscle weakness at the injury site gradually spreading to other areas—until weakness affects respiratory muscles, leading to suffocation.
A growing body of anecdotal observations indicates that nerve damage in the arms or legs may serve as a trigger for ALS development.
1
Research Findings on Nerve Injury & ALS
Researchers at the University of Illinois at Chicago have now provided the first evidence that peripheral nerve injury can initiate and propagate ALS-like conditions in rodent models. Their findings, published in Neurobiology of Disease, revealed that rats genetically modified to develop ALS-like symptoms exhibit an abnormal inflammatory response in the spinal cord region connected to injured peripheral neurons.
For some ALS patients, the disease spreads after weakness first appears in the hands or legs. Notably, the onset site often corresponds to a hand or leg that sustained a recent or prior injury. This observation prompted researchers to investigate how environmental factors like localized nerve injury influence the initiation and progression of ALS.
2
Animal Model & Experimental Results
The study utilized rats carrying the SOD1 gene mutation; these animals had elevated SOD1 enzyme levels and developed ALS-like symptoms, including progressive muscle weakness, starting at 15 weeks of age.
At 10 weeks old, researchers surgically damaged individual leg nerves in both SOD1-mutant rats and wild-type rats. While all rats experienced reduced leg strength post-surgery, wild-type rats recovered nearly completely within a few weeks. In contrast, SOD1-mutant rats never recovered and developed weakness in the opposite leg.
At 10 weeks old, researchers surgically damaged individual leg nerves in both SOD1-mutant rats and wild-type rats. While all rats experienced reduced leg strength post-surgery, wild-type rats recovered nearly completely within a few weeks. In contrast, SOD1-mutant rats never recovered and developed weakness in the opposite leg.
Additional findings showed that surgically injured rats experienced heightened and prolonged inflammation. The number of microglia and astrocytes in the spinal cord area linked to damaged neurons also increased, with inflammation spreading from these cells to adjacent neurons simultaneously.
This inflammatory spread may explain why ALS initially progresses from the injury site. Microglia perform multiple functions, one of which is pruning or eliminating synapses—the junctions connecting nerve cells. These connections are vital for normal neural function and neuron survival during development. In regions with spinal cord inflammation and elevated microglia, synapse numbers triple. Once a neuron loses connection with neighboring cells, those adjacent cells often die.
This chain reaction of cell death likely drives the progressive spread of muscle weakness in ALS.
3
Clinical Implications & Treatment Prospects
By clarifying the link between peripheral nerve injury and ALS onset and progression using a novel animal model, researchers conclude that a key strategy for ALS treatment is halting disease spread immediately after initial onset. As no current therapies can significantly slow or block disease progression, efforts are underway to develop new therapeutic drugs.